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Abstract
Normal abundant dietary sugars such as fructose and glucose can contribute to hypertension and
other health issues. To avoid these health complications, many individuals use artificial sweeteners. An
equivalent intake of some artificial sweeteners also can lead to hypertension. However, Stevia, a
sweetener that is isolated from a Paraguayan plant, was shown in relevant literature to decrease blood
pressure in both rat specimens and humans. The general purpose of this research project was to
study the effect of Stevia and glucose on the expression of two key components of the reninangiotensin-aldosterone system (RAAS): prorenin receptor (PRR) and angiotensin receptor type 1
(AT1). Increased expression of renin and angiotensin can lead to vasoconstriction and systemic
hypertension. Their effects are mediated by their binding to PRR and AT1. Therefore, decreases in the
expression of these receptor proteins can result in lowered blood pressure. Rats were fed diets
supplemented with glucose, saccharin, or Stevia over a six-week period and the kidneys were
obtained. qPCR designs were developed to measure the relative amounts of PRR receptor and AT1
receptor. The methods had efficiencies greater than 97% and gave reproducible results. Then the
developed methods were used to measure the expression of AT1 and PRR in the different rat kidney
samples. A general increase in the relative expression of both AT1 and PRR in the glucose diet was
observed. However, this increase and all other differences in the test groups were not significantly
different than the control group. These results suggest no differences in AT1 or PRR expression for
different sweetener diets.

Results

Rat kidneys

RNA Purification
Table 2. RNA sample concentrations & purity

Rat kidneys collected and quickly frozen in liquid nitrogen

Sample Conc (ng/uL)

RNA isolation
Kidney tissue homogenized (Qiashredders) and RNA isolated (mirVana kit, Ambion)

Long RNAs

E1

592.7

2.01

E2

111.9

1.97

E3

596.7

2.04

E4

439.7

2.02
Figure 5. 15% denaturing gel demonstrating
the separation of short and long RNAs in the
mirVana procedure

RNA quantitation and then Reverse Transcription (High capacity cDNA kit, Life Tech.)

Efficiencies of RT-qPCR Methods

qPCR & Analysis

Threshold Cycle

• The renin-angiotensin-aldosterone system is located
primarily in the kidneys
• It is important in regulating blood pressure and blood
volume.
• Renin and angiotensin are the major proteins in this
system; they bind to prorenin receptor (PRR) and
angiotensin II type 1 receptor (AT1).
• Binding to these receptors lead to local
vasoconstriction and hypertension.
• Hypertension is a serious health problem in the
United States, more than 30% of adults have it.2
• AT1 expression is increased during hypertension.1
• In rats, and increase in fructose & sucrose intake
correlated with an increase in AT1 expression and
hypertension.3,4,5
• In both rats and humans, Stevia was shown to
decrease blood pressure.6,7
• Less information is known about the effects of
sweeteners on prorenin receptor
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qPCR (Gene expression Master Mix, Life Tech.) of cDNA samples and Relative Quantitation using the
Method

Short RNAs

A260/A280

Reverse Transcription

Introduction

Figure 1. Simplified Diagram of Renin-Angiotensin System

Methodology
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Figure 6. Standard curve to determine AT1
system efficiency. System was 97% efficient.

Figure 7. Standard curve to determine PRR
system efficiency. System was 98% efficient.

Relative Expressions of AT1 and PRR mRNAs

Figure 2. Prorenin Receptor System Design. Crossing the exon junction ensures that the
primers and probes are specific for only the mRNA of interest
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Objectives
• To purify mRNA from the rat kidneys and assess its quality
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• To design and test the efficiency of qPCR primers and probes to measure the expression of prorenin
receptor (PRR), angiotensin II type 1 receptor (AT1), and GAPDH (endogenous control)
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• To measure the expression of AT1 and PRR relative to GAPDH in the control and experimental rat
kidneys
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Standard
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Experimental Design
Four groups, four male WKY rats per group
Fed the following liquid diets for 6 weeks:
Standard- liquid osmolite diet
Glucose- liquid osmolite & glucose
Saccharin- liquid osmolite & saccharin
Stevia- liquid osmolite & stevia
Mixed Diet - liquid osmolite (3 weeks), glucose (1 week), stevia (2 weeks) (2 kidneys)
Measured the relative expression of AT1 and PRR

Figure 4. Example Amplification Plot comparing the threshold cycles
(CT) of control and experimental targets. The CT is the cycle where
the fluorescence reaches above baseline fluorescence, generally
during the exponential phase of the curve.
→ ∆CT = CT (target) – CT (control GAPDH)
Figure 3. Diagram of qPCR Theory. As polymerization
→ ∆∆CT = ∆CT – ∆CT (Ref  E2)
occurs, the Fluorophore is cleaved from the probe and
→ RQ = 2^(-∆∆CT)
emits measurable fluorescence

Conclusions
•

Efficient qPCR systems were established for AT1, PRR, and GAPDH.

•

RNA was isolated with consistent purity despite a variance in concentration.

•

No significant differences were found among sample groups, though a slight increase in the relative
quantity of glucose was seen for both targets.

•

The lack of significant differences between diet groups was probably a result of high variance
among biological replicates and small sample sizes.

Table 1. Primers and Probes Designed for AT1, PRR, and GAPDH
Angiotensin II Receptor type 1 (AT1)

Prorenin Receptor (PRR)

Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)

Forward

5' GCTGGCATTTTGTCTGGATAAAT 3'

5’ TCGCTCCCCCTCAATTCTCT 3’

5' ACGGGAAACCCATCACCAT 3'

Reverse

5' GGGTTGAGTTGGTCTCAGACACT 3'

5’ CAGCACTTGCAGTTCAGAAAGAAA 3’ 5' CCAGCATCACCCCATTTGA 3'

Probe

5' AGTGATCACCAGGTCAAGT 3'

5’ GGAATAATGAAGTTGACCTGC 3’

Saccharin

Stevia

Mixed

Diet

Figure 7. Relative AT1 mRNA quantity for each
diet group

Figure 8. Relative PRR mRNA quantity for each
diet group
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